JNK signaling in apoptosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aoki H, Kang PM, Hampe J, Yoshimura K, Noma T, Matsuzaki M et al. (2002). Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 277: 10244–10250.
Barone MC, Desouza LA, Freeman RS . (2008). Pin1 promotes cell death in NGF-dependent neurons through a mechanism requiring c-Jun activity. J Neurochem 106: 734–745.
Behrens A, Sibilia M, Wagner EF . (1999). Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat Genet 21: 326–329.
Björkblom B, Vainio JC, Hongisto V, Herdegen T, Courtney MJ, Coffey ET . (2008). All JNKs can kill, but nuclear localization is critical for neuronal death. J Biol Chem 283: 19704–19713.
Bossy-Wetzel E, Green DR . (1999). Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 274: 17484–17490.
Cano E, Hazzalin CA, Mahadevan LC . (1994). Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol Cell Biol 14: 7352–7362.
Cano E, Mahadevan LC . (1995). Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20: 117–122.
Chauhan D, Li G, Hideshima T, Podar K, Mitsiades C, Mitsiades N et al. (2003). JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J Biol Chem 278: 17593–17596.
Chen YR, Meyer CF, Tan TH . (1996). Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem 271: 631–634.
Chen YR, Tan TH . (2000). The c-Jun N-terminal kinase pathway and apoptotic signaling. Int J Oncol 16: 651–662.
Chen Z, Seimiya H, Naito M, Mashima T, Kizaki A, Dan S et al. (1999). ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 18: 173–180.
Chinnaiyan AM . (1999). The apoptosome: heart and soul of the cell death machine. Neoplasia 1: 5–15.
Dai T, Rubie E, Franklin CC, Kraft A, Gillespie DA, Avruch J et al. (1995). Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells: implications for repression of c-Jun function. Oncogene 10: 849–855.
Deng Y, Ren X, Yang L, Lin Y, Wu X . (2003). A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 115: 61–70.
Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T et al. (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025–1037.
Dhanasekaran DN, Johnson GL . (2007). MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene 26: 3097–3099. Review.
Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP . (2007). Scaffold proteins of MAP-kinase modules. Oncogene 26: 3185–3202. Review.
Donovan N, Becker EB, Konishi Y, Bonni A . (2002). JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem 277: 40944–40949.
Fan M, Chambers TC . (2001). Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy. Drug Resist Updat 4: 253–267.
Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL . (1997). MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev 7: 67–74.
Ferrandi C, Ballerio R, Gaillard P, Giachetti C, Carboni S, Vitte PA et al. (2004). Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Br J Pharmacol 142: 953–960.
Fuchs SY, Adler V, Pincus MR, Ronai Z . (1998). MEKK1/JNK signaling stabilizes and activates p53. Proc Natl Acad Sci USA 95: 10541–10546.
Fujino G, Noguchi T, Matsuzawa A, Yamauchi S, Saitoh M, Takeda K et al. (2007). Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1. Mol Cell Biol 27: 8152–8163.
Gross A, McDonnell JM, Korsmeyer SJ . (1999). BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899–1911.
Hibi M, Lin A, Smeal T, Minden A, Karin M . (1993). Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7: 2135–2148.
Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ . (2004). Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 23: 2134–2145.
Johnson GL, Nakamura K . (2007). The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim Biophys Acta 1773: 1341–1348.
Jones EV, Dickman MJ, Whitmarsh AJ . (2007). Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase. Biochem J 405: 617–623.
Kharbanda S, Saxena S, Yoshida K, Pandey P, Kaneki M, Wang Q et al. (2000). Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J Biol Chem 275: 322–327.
Kolomeichuk SN, Terrano DT, Lyle CS, Sabapathy K, Chambers TC . (2008). Distinct signaling pathways of microtubule inhibitors--vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively. FEBS J 275: 1889–1899.
Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R et al. (2002). Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111: 331–342.
Lei K, Davis RJ . (2003). NK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci USA 100: 2432–2437.
Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB et al. (2002). The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 22: 4929–4942.
Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ . (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183–192.
Liu H, Nishitoh H, Ichijo H, Kyriakis JM . (2000b). Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol 20: 2198–2208.
Liu J, Lin A . (2005). Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15: 36–42.
Liu TC, Huang CJ, Chu YC, Wei CC, Chou CC, Chou MY et al. (2000a). Cloning and expression of ZAK, a mixed lineage kinase-like protein containing a leucine-zipper and a sterile-alpha motif. Biochem Biophys Res Commun 274: 811–816.
Madesh M, Antonsson B, Srinivasula SM, Alnemri ES, Hajnóczky G . (2002). Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization. J Biol Chem 277: 5651–5659.
Marani M, Tenev T, Hancock D, Downward J, Lemoine NR . (2002). Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol Cell Biol 22: 3577–3589.
Matsuzawa A, Ichijo H . (2001). Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1. J Biochem 130: 1–8.
Mei Y, Yuan Z, Song B, Li D, Ma C, Hu C et al. (2008). Activating transcription factor 3 up-regulated by c-Jun NH(2)-terminal kinase/c-Jun contributes to apoptosis induced by potassium deprivation in cerebellar granule neurons. Neuroscience 151: 771–779.
Nagai H, Noguchi T, Takeda K, Ichijo H . (2007). Pathophysiological roles of ASK1-MAP kinase signaling pathways. J Biochem Mol Biol 40: 1–6.
Oleinik NV, Krupenko NI, Krupenko SA . (2007). Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway. Oncogene 26: 7222–7230.
Prasad MV, Dermott JM, Heasley LE, Johnson GL, Dhanasekaran N . (1995). Activation of Jun kinase/stress-activated protein kinase by GTPase-deficient mutants of Gα12 and Gα13. J Biol Chem 270: 18655–18659.
Puthalakath H, Huang DC, O′Reilly LA, King SM, Strasser A . (1999). The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3: 287–296.
Puthalakath H, Strasser A . (2002). Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9: 505–512.
Raman M, Chen W, Cobb MH . (2007). Differential regulation and properties of MAPKs. Oncogene 26: 3100–3112.
Robitaille K, Daviau A, Lachance G, Couture JP, Blouin R . (2008). Calphostin C induced apoptosis is mediated by a tissue transglutaminase-dependent mechanism involving the DLK/JNK signaling pathway. Cell Death Differ. (e-pub ahead of print).
Sánchez-Perez I, Murguía JR, Perona R . (1998). Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16: 533–540.
Schroeter H, Boyd CS, Ahmed R, Spencer JP, Duncan RF, Rice-Evans C et al. (2003). c-Jun N-terminal kinase (JNK)-mediated modulation of brain mitochondria function: new target proteins for JNK signalling in mitochondrion-dependent apoptosis. Biochem J 372: 359–369.
Sluss HK, Barrett T, Dérijard B, Davis RJ . (1994). Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 14: 8376–8384.
Srivastava RK, Mi QS, Hardwick JM, Longo DL . (1999). Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc Natl Acad Sci USA 96: 3775–3780.
Sunayama J, Tsuruta F, Masuyama N, Gotoh Y . (2005). JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J Cell Biol 170: 295–304.
Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K et al. (2001). ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2: 222–228.
Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A et al. (2000). Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870–874.
Tsuruta F, Sunayama J, Mori Y, Hattori S, Shimizu S, Tsujimoto Y et al. (2004). JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 23: 1889–1899.
Turjanski AG, Vaqué JP, Gutkind JS . (2007). MAP kinases and the control of nuclear events. Oncogene 26: 3240–3253.
Uehara T, Bennett B, Sakata ST, Satoh Y, Bilter GK, Westwick JK et al. (2005). JNK mediates hepatic ischemia reperfusion injury. J Hepatol 242: 850–859.
Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S et al. (1996). Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75–79.
Wang XT, Pei DS, Xu J, Guan QH, Sun YF, Liu XM et al. (2007). Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury. Cell Signal 19: 1844–1856.
Westwick JK, Weitzel C, Minden A, Karin M, Brenner DA . (1994). Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem 269: 26396–26401.
Widmann C, Gerwins P, Johnson NL, Jarpe MB, Johnson GL . (1998). MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol Cell Biol 18: 2416–2429.
Wilson DJ, Fortner KA, Lynch DH, Mattingly RR, Macara IG, Posada JA et al. (1996). JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur J Immunol 26: 989–994.
Xu Z, Maroney AC, Dobrzanski P, Kukekov NV, Greene LA . (2001). The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Mol Cell Biol 21: 4713–4724.
Yamamoto K, Ichijo H, Korsmeyer SJ . (1999). BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19: 8469–8478.
Yang DD, Kuan CY, Whitmarsh AJ, Rincón M, Zheng TS, Davis RJ et al. (1997). Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865–870.